Why Is the New York Times Laundering the Reputation of a Sleazy AI Startup That’s Selling GLP-1s via a Dishonest Dumpster Fire of Fake Doctors, Phony Before-and-After Pictures, a Warning From the FDA, and Other Glaring Red Flags?

A critical examination reveals that a controversial AI startup marketing GLP-1 drugs employs deceptive tactics including fake doctors and doctored images, despite FDA warnings. The New York Times is accused of improving the startup's public image amid these concerns.